Mona Wassef

540 citations
36 papers · 410 indexed · h-index 12
Topics
Hemophilia Treatment and Research (11 papers)Antibiotic Resistance in Bacteria (7 papers)Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers)
Partner nations
EgyptAustraliaFrance

In The Last Decade

Mona Wassef

32 papers receiving 382 citations

Peers

Mona Wassef
Comparison fields: 5 of 74
  • Hematology 95
  • Molecular Biology 86
  • Molecular Medicine 80
  • Genetics 71
  • Epidemiology 51
Replace Nihal Martis with:
Nihal Martis France
James M. Kidd United States
H.‐J. Lv China
Albert Matalon United States
Helena Poggi Chile
Evelyne Le Roux France
Ebrahim Rezazadeh Zarandi Iran
V. Vávrová Czechia
Mona Wassef relative to Nihal Martis France Nihal Martis's profile →
Citations per field
00.5×6.3×
Nihal Martis · 1×
Citations per year

Countries citing papers authored by Mona Wassef

Since Specialization
Citations

This map shows the geographic impact of Mona Wassef's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mona Wassef with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mona Wassef more than expected).

Fields of papers citing papers by Mona Wassef

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mona Wassef. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mona Wassef. The network helps show where Mona Wassef may publish in the future.

Co-authorship network of co-authors of Mona Wassef

This figure shows the co-authorship network connecting the top 25 collaborators of Mona Wassef. A scholar is included among the top collaborators of Mona Wassef based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mona Wassef. Mona Wassef is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 5
3 11
4 7
5 13
6 1
7 10
8 12
9 10
10 4
11 25
12 34
13 13
14 0
15 1
16 31
17 31
18
Continuous subcutaneous infusion of glucagon by portable pump in non beta cell tumor hypoglycemia.
1
19 7
20 37

About Mona Wassef

Mona Wassef is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Hematology, having authored 36 papers that have together received 410 indexed citations. Recurring topics across this work include Hemophilia Treatment and Research (11 papers), Antibiotic Resistance in Bacteria (7 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers). The work is most often cited by research in Molecular Medicine (80 citations), Applied Microbiology and Biotechnology (27 citations) and Hematology (95 citations). Mona Wassef has collaborated with scholars based in Egypt, Australia and France. Frequent co-authors include A. Aronstam, David McLellan, Doaa Ghaith, Hanan Fouad, Dina Sabry, Emad Abada, Nathalie Kubis, A Ryckewaert, A Dryll and Oliver Meyer. Their work appears in journals such as The Lancet, The Journal of Pediatrics and Journal of Clinical Pathology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026